DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8+ T cells independently of PD-1 and PD-L1

International Immunology

Volumn 25, Issue 11, 2013, Pages 651-660

  Mukherjee, Gayatri ^a   Geliebter, Ari ^a   Babad, Jeffrey ^a   Santamaria, Pere ^b,c,d   Serreze, David V ^e   Freeman, Gordon J ^f,g   Tarbell, Kristin V ^h   Sharpe, Arlene ^g,i   DiLorenzo, Teresa P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^e JACKSON LABORATORY   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Autoimmunity; Diabetes; NOD mice

Indexed keywords

BLOCKING ANTIBODY; CELL RECEPTOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DEC 205 PROTEIN; GLUCOSE 6 PHOSPHATASE; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DIABETOGENESIS; FEMALE; GENE DELETION; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; STEADY STATE;

AUTOIMMUNITY; DIABETES; NOD MICE;

ANIMALS; ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS; ANTIGENS, CD; ANTIGENS, CD274; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; LECTINS, C-TYPE; LYMPHOCYTE COUNT; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; PROGRAMMED CELL DEATH 1 RECEPTOR; RECEPTORS, CELL SURFACE;

EID: 84886440668     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxt031     Document Type: Article

References (50)

1. Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C. and Steinman, R. M. 2002. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196:1627.
2. Hawiger, D., Inaba, K., Dorsett, Y. et al. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769.
3. Mukhopadhaya, A., Hanafusa, T., Jarchum, I. et al. 2008. Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice. Proc. Natl. Acad. Sci. USA 105:6374.
4. Hawiger, D., Masilamani, R. F., Bettelli, E., Kuchroo, V. K. and Nussenzweig, M. C. 2004. Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo. Immunity 20:695.
5. Stern, J. N., Keskin, D. B., Kato, Z. et al. 2010. Promoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cells. Proc. Natl. Acad. Sci. USA 107:17280.
6. Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M. C. and von Boehmer, H. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6:1219.
7. Mahnke, K., Qian, Y., Knop, J. and Enk, A. H. 2003. Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood 101:4862.
8. Yamazaki, S., Dudziak, D., Heidkamp, G. F. et al. 2008. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J. Immunol. 181:6923.
9. Luo, X., Herold, K. C. and Miller, S. D. 2010. Immunotherapy of type 1 diabetes: where are we and where should we be going? Immunity 32:488.
10. Jiang, W., Swiggard, W. J., Heufler, C. et al. 1995. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375:151.
11. Bonifaz, L. C., Bonnyay, D. P., Charalambous, A. et al. 2004. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199:815.
12. Mahnke, K., Guo, M., Lee, S. et al. 2000. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J. Cell Biol. 151:673.
13. Inaba, K., Swiggard, W. J., Inaba, M. et al. 1995. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes. Cell. Immunol. 163:148.
14. Vremec, D., Pooley, J., Hochrein, H., Wu, L. and Shortman, K. 2000. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164:2978.
15. Henri, S., Vremec, D., Kamath, A. et al. 2001. The dendritic cell populations of mouse lymph nodes. J. Immunol. 167:741.
16. Amrani, A., Verdaguer, J., Serra, P., Tafuro, S., Tan, R. and Santamaria, P. 2000. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406:739.
17. Han, B., Serra, P., Amrani, A. et al. 2005. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide. Nat. Med. 11:645.
18. Niens, M., Grier, A. E., Marron, M., Kay, T. W., Greiner, D. L. and Serreze, D. V. 2011. Prevention of "Humanized" diabetogenic CD8 T-cell responses in HLA-transgenic NOD mice by a multipeptide coupled-cell approach. Diabetes 60:1229.
19. Scott, G. S., Fishman, S., Khai Siew, L. et al. 2010. Immunotargeting of insulin reactive CD8 T cells to prevent diabetes. J. Autoimmun. 35:390.
20. Tsai, S., Shameli, A., Yamanouchi, J. et al. 2010. Reversal of autoimmunity by boosting memory-like autoregulatory T cells. Immunity 32:568.
21. Vincent, B. G., Young, E. F., Buntzman, A. S. et al. 2010. Toxincoupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice. J. Immunol. 184:4196.
22. Lieberman, S. M., Evans, A. M., Han, B. et al. 2003. Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 100:8384.
23. Trudeau, J. D., Kelly-Smith, C., Verchere, C. B. et al. 2003. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J. Clin. Invest. 111:217.
24. Lieberman, S. M., Takaki, T., Han, B., Santamaria, P., Serreze, D. V. and DiLorenzo, T. P. 2004. Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase. J. Immunol. 173:6727.
25. Mallone, R., Martinuzzi, E., Blancou, P. et al. 2007. CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes. Diabetes 56:613.
26. Amrani, A., Serra, P., Yamanouchi, J. et al. 2001. Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation. J. Immunol. 167:655.
27. Francisco, L. M., Sage, P. T. and Sharpe, A. H. 2010. The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev. 236:219.
28. Keir, M. E., Freeman, G. J. and Sharpe, A. H. 2007. PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues. J. Immunol. 179:5064.
29. Probst, H. C., McCoy, K., Okazaki, T., Honjo, T. and van den Broek, M. 2005. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 6:280.
30. Verdaguer, J., Schmidt, D., Amrani, A., Anderson, B., Averill, N. and Santamaria, P. 1997. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186:1663.
31. Santamaria, P., Utsugi, T., Park, B. J., Averill, N., Kawazu, S. and Yoon, J. W. 1995. Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences. J. Immunol. 154:2494.
32. Graser, R. T., DiLorenzo, T. P., Wang, F. et al. 2000. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. J. Immunol. 164:3913.
33. DiLorenzo, T. P., Lieberman, S. M., Takaki, T. et al. 2002. During the early prediabetic period in NOD mice, the pathogenic CD8(+) T-cell population comprises multiple antigenic specificities. Clin. Immunol. 105:332.
34. Takaki, T., Lieberman, S. M., Holl, T. M. et al. 2004. Requirement for both H-2Db and H-2Kd for the induction of diabetes by the promiscuous CD8+ T cell clonotype AI4. J. Immunol. 173:2530.
35. Prochazka, M., Serreze, D. V., Worthen, S. M. and Leiter, E. H. 1989. Genetic control of diabetogenesis in NOD/Lt mice. Development and analysis of congenic stocks. Diabetes 38:1446.
36. Barber, D. L., Wherry, E. J., Masopust, D. et al. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439:682.
37. Butte, M. J., Keir, M. E., Phamduy, T. B., Sharpe, A. H. and Freeman, G. J. 2007. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 27:111.
38. Dudziak, D., Kamphorst, A. O., Heidkamp, G. F. et al. 2007. Differential antigen processing by dendritic cell subsets in vivo. Science 315:107.
39. Cheong, C., Choi, J. H., Vitale, L. et al. 2010. Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody. Blood 116:3828.
40. Jarchum, I., Takaki, T. and DiLorenzo, T. P. 2008. Efficient culture of CD8(+) T cells from the islets of NOD mice and their use for the study of autoreactive specificities. J. Immunol. Methods 339:66.
41. Samanta, D., Mukherjee, G., Ramagopal, U. A. et al. 2011. Structural and functional characterization of a single-chain peptide-MHC molecule that modulates both naive and activated CD8+ T cells. Proc. Natl. Acad. Sci. USA 108:13682.
42. Liang, S. C., Latchman, Y. E., Buhlmann, J. E. et al. 2003. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 33:2706.
43. Yamazaki, T., Akiba, H., Iwai, H. et al. 2002. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169:5538.
44. Ansari, M. J., Salama, A. D., Chitnis, T. et al. 2003. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198:63.
45. Keir, M. E., Liang, S. C., Guleria, I. et al. 2006. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203:883.
46. Butte, M. J., Pena-Cruz, V., Kim, M. J., Freeman, G. J. and Sharpe, A. H. 2008. Interaction of human PD-L1 and B7-1. Mol. Immunol. 45:3567.
47. Paterson, A. M., Brown, K. E., Keir, M. E. et al. 2011. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo. J. Immunol. 187:1097.
48. Krishnamurthy, B., Dudek, N. L., McKenzie, M. D. et al. 2006. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J. Clin. Invest. 116:3258.
49. Edwards, A. D., Chaussabel, D., Tomlinson, S., Schulz, O., Sher, A. and Reis e Sousa, C. 2003. Relationships among murine CD11c(high) dendritic cell subsets as revealed by baseline gene expression patterns. J. Immunol. 171:47.
50. Segura, E., Kapp, E., Gupta, N. et al. 2010. Differential expression of pathogen-recognition molecules between dendritic cell subsets revealed by plasma membrane proteomic analysis. Mol. Immunol. 47:1765.